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We have performed a review of literature to ﬁnd evidence on the effectiveness of the different methods
used to decrease pain perception during ofﬁce hysteroscopy and identify risk factors of a painful hys-
teroscopy. Our methods include a review of literature following the Meta-analysis of Observational
Studies in Epidemiology (MOOSE) Guidelines for Systematic Reviews of Observational Studies; a litera-
ture search of MEDLINE, Embase, PubMed, and the Cochrane Library of Systematic Reviews; and refer-
ence search in selected papers, looking for meta-analysis and randomized controlled trials that assess
pain management in ofﬁce hysteroscopy and studies that identify risk factors for painful hysteroscopy.
Review for appropriateness and allocation according to type of analgesic method was performed,
together with evaluation for risk factors and evidence of pain reduction effects of pharmacological and
nonpharmacological analgesic methods. Nonpharmacological methods, such as vaginoscopy or mini-
hysteroscopes, are advisable to avoid producing pain. The only pharmacological method that has
demonstrated its effectiveness in several meta-analysis and reviews is paracervical block, reducing pain
during and 30 minutes after hysteroscopy. Nonsteroidal anti-inﬂammatory drugs (NSAIDs) seem to be
useful in the postoperative period. Evidence is not clear about combination of techniques or misoprostol.
Although this review is limited because of heterogeneity of the studies included, it gives a wide overview
of the different methods that are available to alleviate pain in ofﬁce hysteroscopy. Paracervical inﬁltration
is the only anesthetic procedure that has proven effective for pain reduction. Other methods such as
using NSAIDs, topical anesthetics, misoprostol, or nitrous oxide have to be better studied to reach
conclusions on their effectiveness.
Copyright © 2016, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Outpatient hysteroscopy in the ofﬁce setting is often the
preferred procedure for diagnosis of intrauterine pathology and
abnormal uterine bleeding, as well as for therapeutic operative
treatment and transcervical sterilization. It is desirable to attempt
to perform as many procedures as possible with ofﬁce hysteros-
copy, as long as they take place in a safe and effective fashion.
Ofﬁce hysteroscopy is a diagnostic and operative technique with
many advantages compared with operating room-based hysteros-
copy: it does not require hospital admission, preoperatory tests,s of interest relevant to this
3, 28049 Madrid, Spain.
m (C. del Valle).
n for Gynecologic Endoscopy and Mi
s.org/licenses/by-nc-nd/4.0/).and general or regional anesthesia. Importantly, it has decreased
postsurgical recovery period, global cost of the procedure, and rate
of complications such as cervical tears, uterine perforation, and
those due to distension media. Although it is generally well toler-
ated, pain, vagal syndrome, hypotension, and uneasiness are com-
mon among patients undergoing hysteroscopy.
Although a ‘no-touch’ approach can be achieved in a large per-
centage of cases without anesthesia, pain is still the main cause of
ofﬁce hysteroscopy failure.1e3 Factors related to pain experience
during hysteroscopy are still not well-known. In addition, there is
controversy about anesthesia and analgesia for outpatient hyster-
oscopy, as there is not enough high-quality evidence.
According to Nagele et al,1 84% of failed hysteroscopies are due
to excessive discomfort. De Iaco et al.2 state that 34.8% of patients
who undergo anesthesia-free diagnostic hysteroscopy report se-
vere pain. Carvalho et al3 report moderate to severe pain [measurednimally Invasive Therapy. Published by Elsevier Taiwan LLC. This is an open access article
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examination] in 68.4% of patients.
An adequate knowledge of anatomy is essential to understand
the physiology of pain in hysteroscopy. Anatomical structures of the
female pelvis are innervated by two pathways. The fundus of the
uterus is innervated by sympathetic ﬁbers from T10 to L2 via the
inferior hypogastric plexus, which enters the uterus by the utero-
sacral ligaments and by the infundibulopelvic ligament, forming
the ovarian plexuses.4 The upper vagina, cervix, and lower uterine
segment are innervated by parasympathetic ﬁbers from S2 to S4,
which form the Frankenhauser or uterovaginal plexus, which en-
ters the uterus following the cardinal ligaments.4,5 Myometrium
and endometrium are innervated by a plexus at the myome-
trialeendometrial interface. Only the basal third of the endome-
trium is innervated.6 Myometrial innervation can vary with disease
processes such as endometriosis or adenomyosis.7
Considering hysteroscopic techniques, pain is mainly produced
when speculum or tenaculum are placed, with cervical dilation,
passage of the hysteroscope through the cervical canal, and
distension of the uterus with ﬂuid. Operative procedures that
damage the endometrial walls, such as endometrial biopsy, poly-
pectomy or myomectomy, ablation or tubal sterilization, are also
painful.3,8,9
Munro and Brooks5 suggest that due to this complex innerva-
tion, successful anesthesia requires simultaneous targeting of more
than one site, including paracervical and intracervical anesthesia
and topical agents in the cervical canal and endometrial cavity.
To avoid pain, the less possible harm has to be done during
hysteroscopy. This includes performing a ‘no-touch’ approach
(direct entry with vaginoscopy and hydrodistension of the cervix
for dilation, while avoiding the use of speculum and tenaculum)
and the use of small caliber instruments. Moreover, normal saline
has been shown to be more comfortable and safer than carbon
dioxide and glycine as distension medium.10 Although it is thought
that warming the distension ﬂuid to physiological temperature
(37.5C) decreases perceived pain, it has not been proven.11 Sagiv
et al performed a randomized controlled study of 126 patients
comparing vaginoscopy without anesthesia to hysteroscopy with
speculum and tenaculum placement and paracervical block. The
mean VAS scores were 3.8 and 5.3 in the vaginoscopic and tradi-
tional groups, respectively.12
In addition, a smaller outer diameter of the hysteroscope de-
creases pain perceived by the patients. Technological improve-
ments have enabled minimization of the caliber of hysteroscopes
(minihysteroscopes 3.5 mm) and instruments. Reduction in outer
diameter by 1 mm or 2 mm as well as reduction in total hystero-
scope size reduces the section of area of the instrument by 50e75%.
The passage of the minihysteroscope through the cervical canal is
consequently smoother, causing less pain. Flexible hysteroscopes
have also been developed, making it easier to follow the canal
pathway.13
However, this ‘no-touch’ technique is not always feasible, and
even when it is possible, it is still sometimes painful. For this
reason, identiﬁcation of risk factors for a painful procedure has to
be done.
The objective of this review of literature is to identify the factors
that inﬂuence pain perceived by patients undergoing hysteroscopy
and study the different anesthetic and analgesic methods that are
used in ofﬁce hysteroscopy to get the clearer possible view of the
ideal method for pain control according to the available evidence.
Materials and methods
A comprehensive literature search has been conducted by a
team of medical investigators (including gynecologists, apharmacologist, and epidemiologist) to identify studies published
in English that evaluate pain during outpatient hysteroscopy and
analgesic and anesthetic methods for pain management in outpa-
tient hysteroscopy. The study population includes women under-
going ofﬁce hysteroscopy. Searched databases include MEDLINE,
Embase, PubMed, and the Cochrane Library of Systematic Reviews.
We used a combination of the following keywords: “hysteroscopy”,
“ofﬁce hysteroscopy”, “pain”, “VAS”, “anesthetics”, “vaginoscopy”,
“analgesics”, “NSAIDs”, “local anesthesia”, and “paracervical block”.
We searched for meta-analysis and randomized controlled studies
mainly from 2000 to 2015, but other types of relevant studies and
reviews have also been included, when no or only a few random-
ized trials were found. Reference sections of the selected papers
were also searched for relevant studies to ensure a wide high-
quality review.
Of the 49 initially selected papers, 16 were excluded after
reading the abstract and methods because pain outcomes were not
reported or operating-room procedures were included. No un-
published studies were included. No authors were contacted dur-
ing the selection.
Database search and careful selection threw three meta-
analyses, six reviews, 17 randomized clinical trials, one controlled
trial without randomization, two cohort studies, and four obser-
vational studies from 2000 to 2015 that were suitable for this re-
view. Some of the papers that were included are not speciﬁc to
ofﬁce hysteroscopic procedures,9,14 but have been selected because
they provide useful information. All the papers assess pain man-
agement during ofﬁce hysteroscopy; however, there is heteroge-
neity regarding their approach on this subject. Possible
confounding factors are the fact that the included studies have
different designs, making it difﬁcult to compare and contrast them,
and that they include different analgesic methods, and compari-
sons with placebo, control group, or other methods, thus making
analysis even more difﬁcult. Stratiﬁcation or regression on possible
predictors of study results, as well as sensitivity testing could
therefore not be performed (Tables 1 and 2). Quality assessment of
the trials that have been reviewed is presented in Table 3.
Results and Discussion
Several studies have been performed to establish risk and pro-
tective factors for suffering pain during hysteroscopy. de Freitas
Fonseca et al.15 observed 558 patients who underwent outpatient
hysteroscopy without anesthesia with vaginoscopic approach,
looking for predictors of unacceptable pain. Carta et al16 did the
same with 284 women attending their clinic. Factors most associ-
ated with pain are severe dysmenorrhea and dyspareunia,15
menopause, nulliparity, and chronic pelvic pain.3,16
Anxiety, although it is difﬁcult to assess, also has a role in pain
perception.16,17 Methods for controlling anxiety have been pro-
posed to reduce pain perception. Reducing waiting time has a
statistically signiﬁcant positive correlation, even if weak, with pain
perception during hysteroscopy (r ¼ 0.45; p < 0.01). However,
anxiety per se, measured by values of anxiety state (State-Trait
Anxiety Inventory scales), was not signiﬁcantly correlated with
pain.16 A randomized trial using music to reduce anxiety during
hysteroscopy has proven that it decreases anxiety and pain
perceived during the procedure [VAS score 4.83 (no music group)
vs. 2.95 (music group); p < 0.001]. It also reduces systolic blood
pressure and heart rate and, according to Angioli et al,17 distracts
the patient from anxietydprovoking thoughts and makes them
focus in more pleasant stimuli.
Procedure-related risk factors for pain during hysteroscopy are
the use of 5 mm or wider hysteroscopes, speculum, tenaculum,
cervical dilators, carbon dioxide for uterine distension, resection of
Table 1
Characteristics of studies identifying risk factors for a painful hysteroscopy.
Study Type of study Participants Intervention Comparison Outcome measure Data reported
De Freitas et al.15 Prospective
observational study
Women
undergoing ofﬁce
hysteroscopy with
no analgesia or
sedation
Hysteroscopy with 3.5-
mm outer diameter
sheath and vaginoscopy
approach
No analgesia for all
patients
Verbal Rating Scale
(VRS): 0e10, 0 min and
15 min after the
procedure,
dichotomized to
acceptable (VRS < 7) or
unacceptable pain
(VRS > 7)
Percentage
Cicinelli13 Review Women
undergoing
diagnostic and
operative
hysteroscopy
Review of observational
and randomized
controlled studies
Pain with traditional
hysteroscopy,
vaginoscopy, and
paracervical block
Visual Analog Scale
(VAS)
Mean (SD) or median (range)
Carta et al.16 Prospective
observational study
Women
undergoing
hysteroscopy
Diagnostic
hysteroscopy with
endometrial biopsy
Pain and anxiety rates
before and after the
procedure
State-Trait Anxiety
Inventory and VAS
Odds ratio
Carvalho et al.3 Cohort Patients
undergoing
diagnostic
hysteroscopy
Anesthesia-free
diagnostic
hysteroscopy
Pain at the end of the
procedure and at
15 min, 30 min, and
60 min after.
VAS Median
SD ¼ standard deviation.
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Carvalho et al3 report 30% more risk of pain when procedures
exceed 3 minutes.
Protective factors against unacceptable pain are a higher degree
of hysteroscopist experience (reducing the risk by half), and a ‘no-
touch’ approach.13,16
Patients with high risk factors of suffering a painful procedure
may be candidates for anesthesia. Although many studies have
been performed about anesthesia in hysteroscopy, there is no ideal
anesthetic and, conversely, sometimes anesthesia delivery can be
more painful than not receiving any anesthesia, as occasionally
occurs with intracervical, paracervical, and topical cervical
anesthesia.18,19
Anesthetic and analgesic methods reported in literature for
outpatient hysteroscopy include oral and intravenous analgesia;
nonopioid analgesics such as nonsteroidal anti-inﬂammatory drugs
(NSAIDs) or paracetamol; opioid analgesics; intrauterine, para-
cervical, transcervical, or uterosacral local anesthetics; and spray,
gel, and cream topical anesthetics.20
NSAIDs are systemic analgesics that decrease uterine activity
and pain by inhibiting cyclooxygenase and reducing circulating
prostaglandins. They are effective in decreasing pain in some gy-
necologic procedures, especially in the postsurgical period. They
include naproxen, diclofenac, ibuprofen, and ketorolac.9 However,
studies throw controversial results regarding the use of NSAIDs in
hysteroscopic procedures. Tam and Yuen21 found no beneﬁcial ef-
fects from oral diclofenac given 1e2 hours before the procedure
during and after conventional hysteroscopy. Hassa et al22 were also
unable to demonstrate a beneﬁt in pain reduction with the use of
100-mg rectal diclofenac 60 minutes before outpatient hysteros-
copy in a randomized controlled trial in nulliparous infertile
women. Ketoprofen has also failed to decrease intraoperative pain,
but seemed effective for postoperative pain after hysteroscopy.23
Ketoprofen VAS scores during and immediately after hysterosco-
py were higher than misoprostol VAS scores in a randomized
controlled trial.24
Acetaminophen also inhibits cyclooxygenase, acting in the
central nervous system instead of the periphery. It is a good option
in cases of allergy or intolerance to NSAIDs.9 Mefenamic acid, a
prostaglandin synthesis inhibitor, also reduces circulating prosta-
glandins.1 Controversially, a randomized placebo controlled trial
concluded that mefenamic acid (500 mg) given 1 hour beforeoutpatient hysteroscopy is not superior to placebo in reducing
discomfort during the procedure but signiﬁcantly reduced post-
operative pain (30 minutes and 60 minutes after the procedure).1
A Cochrane Review meta-analysis, Pain relief for outpatient
hysteroscopy, did not demonstrate any signiﬁcant reduction with
NSAIDs or opioid analgesics during or after the procedure.20
Nevertheless, the Royal College of Obstetricians and Gyneacolo-
gists Green-top Guideline Number 59 advises women without
contraindications to take a standard dosage of NSAIDs 1 hour before
hysteroscopy to reduce pain in the immediate postoperative
period.25
Opioids have also been used for pain treatment in hysteroscopy.
They produce analgesic effects through interaction with endoge-
nous opioid mu receptors. They provide analgesic effects and cause
euphoria. The most frequently used opioid for gynecologic pro-
cedures is fentanyl, which causes moderate sedation with a rapid
onset and brief duration. It can be reversed by naloxone.9 The only
randomized study on opioid analgesics that we found in our liter-
ature search was performed by Lin et al.26 They stated that sub-
lingual buprenorphine is not only unhelpful in relieving pain
associated with hysteroscopy, but is also associated with signiﬁcant
adverse reactions. It reported 38.8% of adverse reactions, including
5% drowsiness, 2.5% nausea or vomiting, and 31.3% of both. The high
incidence of these adverse effects limits the use of opioids in the
outpatient setting.20
To reduce intraoperative pain, other analgesic or anesthetic
methods may be considered, such as local anesthesia. According to
the aforementioned Cochrane Review, only local anesthetics pro-
vide a signiﬁcant reduction in the mean pain scores during and
30 minutes after the procedure.20 They include paracervical,
intracervical, transcervical, or uterosacral block and topical appli-
cation in spray, cream, or gel form. The British Medical Journal
meta-analysis by Cooper et al18 found that intracervical and para-
cervical injections of local anesthetic signiﬁcantly reduced pain in
women undergoing outpatient hysteroscopy, whereas transcervical
and topical application did not. Paracervical injection was signiﬁ-
cantly superior to the other anesthetic methods. They also
concluded that local anesthetics did not have a signiﬁcant effect on
the incidence of vasovagal episodes. Munro and Brooks' review of
local anesthesia for ofﬁce hysteroscopy also supports that a
consistent positive anesthetic effect is only demonstrated with
paracervical anesthesia. Five of the six randomized clinical trials
Table 2
Characteristics of studies that assess pain reduction using pharmacological/nonpharmacological methods.
Study Type of study Participants Intervention Comparison Outcome measure Data reported
Ahmad et al.20 Cochrane
systematic review
and meta-analysis
Randomized controlled trials
(RCTs) investigating
pharmacological interventions
for pain relief during
hysteroscopy
Systematic review and meta-
analysis
1. Analgesics versus placebo/no
treatment
2. Analgesics versus other
analgesics
Reduction in the mean pain
score
Standardized mean
difference (SMD)
Tangsiriwatthana et al.14 Systematic review RCTs involving women who
underwent cervical dilation and
uterine intervention
Systematic review Paracervical versus placebo for
cervical dilation and uterine
intervention
Reduction in the mean pain
score
SMD
Kaneshiro et al.27 Systematic review RCTs evaluating pain
management at the time of
sterilization by hysteroscopy
Systematic review 1. Paracervical block with
lidocaine versus normal saline
2. Intravenous conscious
sedation versus oral analgesia
Visual Analog Scale (VAS) Mean (SD)
Cooper et al.18 Systematic review
and meta-analysis
Women undergoing diagnostic
or operative hysteroscopy as
outpatients
Systematic review and meta-
analysis
Different types of local
anesthetics
VAS
Incidence of vasovagal episodes
SMD
Percentage
Munro and Brooks5 Review Published RCT comparing local
anesthesia with placebo or no
treatment for the performance
of ofﬁce hysteroscopy
Review Intracervical/paracervical/
topical intracavitary/topical
cervical/combined local
anesthesia versus placebo/no
treatment
Reduction in pain SMD
Kabli and Tulandi32 Randomized trial Women undergoing outpatient
hysteroscopy
Hysteroscopy under local
anesthesia with 2 mL of 1%
lidocaine or local and
intrauterine anesthesia with
18 mL of lidocaine in 250 mL of
saline as distension medium
Local cervical versus combined
cervical and intrauterine
anesthesia
VAS during the procedure and
at 10 min, 30 min, and 60 min
after the procedure
Median (SD)
Al-Sunaidi and Tulandi30 Randomized trial Women undergoing outpatient
hysteroscopy for evaluation of
the uterine cavity
Local anesthesia with 0.2 mL of
0.5% bupivacaine
hydrochloride. Paracervical
anesthesia with 4 mL of 0.5%
bupivacaine hydrochloride at 3
o'clock and 9 o'clock positions
of the fornix
Local intracervical versus
combined local and
paracervical anesthesia
VAS during the procedure and
at 10 min, 30 min, and 60 min
after
Mean (SD)
Chudnoff et al.28 Randomized
controlled trial
Women undergoing
hysteroscopic sterilization
Paracervical anesthesia with
11 mL of 1% lidocaine.
Paracervical injection of 11 mL
normal saline
Paracervical block versus
placebo
VAS at injection, tenaculum
placement, introduction of
hysteroscope through external
and internal os, and placement
of tubal devices
Mean (SD)
Lukes et al.29 Randomized trial Women undergoing
hysteroscopical removal of
uterine polyps and myomas
using MyoSure device
Paracervicaleintracervical
injection or only intracervical
block of 1:1 mixture of 1%
lidocaine and 0.25%
bupivacaine
Paracervicaleintracervical
block versus intracervical block.
WongeBaker Faces Rating Scale
0e10
Mean (SD)
Issat et al.24 Randomized
controlled trial
Women undergoing outpatient
hysteroscopy
400 mg vaginal misoprostol/
50 mg/mL (intravenously)
intravenous (i.v.) ketoprofen in
100 mL of 5% i.v. glucose/
100 mL of 5% i.v. glucose/
vaginal placebo tablets
Group 1: vaginal misoprostol
and 100 mL of 5% i.v. glucose.
Group 2: i.v. ketoprofen and
placebo vaginal tablets. Group
3: 100 mL of 5% i.v. glucose and
placebo tablets
VAS before, during, and at 5min
and 15 min after the procedure
Median (range)
Esin et al. 36 Randomized
controlled trial
Premenopausal women
undergoing ofﬁce hysteroscopy
200 mg sublingual misoprostol
2 h before hysteroscopy or
xylocaine pump spray 10%
during the procedure
Group 1: sublingual
misoprostol and placebo spray
Group 2: lidocaine pump spray
and placebo tablets
VAS during and 10min after the
procedure
Mean (SD)
Hassa et al.22 Randomized
controlled trial
Primarily infertile women who
underwent outpatient
200-mg vaginal misoprostol 6 h
before hysteroscopy or 100 mg
Group 1: 200-mg vaginal
misoprostol and placebo tablets
rectally.
VAS during hysteroscopy Median (range)
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C. del Valle et al. / Gynecology and Minimally Invasive Therapy 5 (2016) 141e147 145that their review included demonstrated reduced pain in pa-
tients who received paracervical anesthesia compared with
placebo.5 Paracervical anesthesia is also effective in hystero-
scopic tubal sterilization, but only for passage of the hysteroscope
through the cervical canal and for cervical manipulation, not for
tubal insertion of the devices.27,28
Although the Cochrane Review of paracervical local anes-
thesia for uterine intervention does not recommend the use of
paracervical injection because it does not reduce intraoperative
pain, this does not apply to ofﬁce hysteroscopy, as the review
includes procedures that require cervical dilation. Exclusively
local anesthesia is not recommended by the Cochrane Review if
cervical dilation is needed.13
Combined cervical block protocols have been studied for
resection of polyps and myomas by hysteroscopy.29,30 Lukes
et al's29 randomized trial found a statistically signiﬁcant differ-
ence in pain score between a group receiving paracervical and
intracervical block and a group only receiving intracervical block
(1.3 vs. 2.1, respectively). This is supported by another clinical
trial, which demonstrated a signiﬁcant decrease of pain with
combined paracervical/intracervical anesthesia during and after
30 minutes of the procedure.30
There are very few studies assessing intrauterine transcervical
local anesthesia. Whereas one randomized study proved that
instillation of 5 mL of 2% lidocaine in the uterine cavity is effec-
tive for hysteroscopy-related pain,31 lidocaine diluted in saline as
distension medium was ineffective in another.32
Topical application of local anesthetic does not reduce the
pain of the hysteroscopy but should be used when a tenaculum is
applied to the cervix.9,18 There are no differences in pain scores
for tenaculum placement between lidocaine spray and gel ac-
cording to Costello et al33 (median in VAS scale of 18.5 and 15.3,
respectively; p ¼ 0.61).
One limitation of studies that assess local anesthesia is that
they might not take into account the pain experienced by the
patients during the injection of local anesthetic, which is a
painful procedure itself.18 A certain time is usually left for the
local anesthetic to be effective, and that might not be considered
by the patient when asked about the pain felt during hysteros-
copy. Moreover, speculum placement is considered by some au-
thors as one of the most painful parts of hysteroscopy, as well as
the injection of anesthetics, and could limit the beneﬁcial effect
of local anesthesia.18,19 Keyhan and Munro19 in a retrospective
cohort study assessing multimodality local anesthesia found that
pain associated with anesthesia application was rated higher
than pain associated with the procedure itself for diagnostic
hysteroscopy [2.7 (anesthesia score) vs. 2.1 (procedure score)].
The main issue of studies that assess local anesthesia for
hysteroscopy is that there is no uniﬁcation of concept of local
anesthetics block, with different sites and depths of injection in
each study, and the use of different anesthetics, concentrations,
volumes, and time from injection to procedure.5
Another issue is the low knowledge about local anesthetics
toxicity and management of their complications. According to
Allen,9 the most common local anesthetics used in the ofﬁce are
lidocaine or bupivacaine, associated with fewer allergic reactions
and lower cost. Lidocaine has a rapid onset of action with inter-
mediate duration. Toxicity is intermediate with an estimated
adult toxic dose of 4 mg/kg (higher when used with epineph-
rine). It provides good topical anesthesia at 1e4% concentration,
but results in a high level of vascular absorbance. Mepivacaine
has a rapid onset, intermediate duration, and intermediate
toxicity. Inﬁltration at 1% concentration provides 1.5e3 hours of
anesthesia. Bupivacaine has a slow onset, long duration, and high
toxicity potential (toxic dose: 2.5e3mg/kg), providing 2e4 hours
Table 3
Methodological quality assessment (Jadad scoring system) of trials included in the review that assess pain reduction with pharmacological/nonpharmacological methods.
Study Randomized ±1a Double blind ±1a Withdrawals and dropouts Total Quality (>3 high)
Al-Sunaidi and Tulandi30 1 1 0 0 1 3 Low
Costello et al.33 1 1 1 1 1 5 High
Kabli and Tulandi32 1 1 0 0 1 3 Low
Lau et al.31 1 1 1 1 1 5 High
Sagiv et al.12 1 1 0 0 1 3 Low
Shankar et al.10 1 1 0 0 1 3 Low
Chudnoff et al.28 1 1 1 1 0 4 High
Lukes et al.29 1 1 0 0 1 3 Low
Issat et al.24 1 1 1 1 0 4 High
Esin et al.36 1 1 1 1 1 5 High
Hassa et al.22 1 1 1 1 1 5 High
Nagele et al.1 1 1 1 1 0 4 High
Lin et al.26 1 1 0 0 0 0 Low
Angioli et al.17 1 1 0 0 0 2 Low
a Description of randomization and blinding: If methods are described and are adequate, an extra point is added; if not, it is deducted.
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methemoglobinemia and cyanosis, visual disturbances, confusion,
seizures, and ventricular tachycardia or ﬁbrillation.34 Techniques to
lower the risk of toxicity include adding vasopressin or epinephrine
to reduce systematic absorption and aspirating before injecting to
avoid intravascular instillation.9
Besides anesthetics or NSAIDs, some studies have assessed the
use of misoprostol, a prostaglandin E1 analog used for cervical
ripening, in ofﬁce hysteroscopy. It may facilitate the hysteroscopic
procedure and lower the risk of cervical laceration because it di-
lates and softens the cervix. It may be self-administered by the
patient (rectal or sublingually) and has no effect on the no-touch
technique of outpatient hysteroscopy.22 Nevertheless, there is no
consensus in literature on the effect of misoprostol in hysteroscopy.
Vaginal misoprostol (400 mg) administered rectally the day before
hysteroscopy in Sordia-Hernandez et al's study35 provided a
considerable decrease of pain and time of the procedure. However,
this was an unblinded studywith a high risk of observational bias. A
randomized trial comparing sublingual misoprostol with lidocaine
spray reported signiﬁcantly lower VAS scores with misoprostol.36
Conversely, this was not conﬁrmed in three randomized clinical
trials, in which there was an increase in preoperative pain and
vaginal bleeding.22,37,38 Misoprostol was not assessed in the
Cochrane Reviews and meta-analysis of pain management in
outpatient hysteroscopy, pain management for tubal sterilization
by hysteroscopy, anesthesia for cervical dilation and uterine inter-
vention, and the British Medical Journal meta-analysis of pain
control in outpatient hysteroscopy.2,18,20,27 No reviews on miso-
prostol for ofﬁce hysteroscopy were found. There is a lack of
consensus evidence and that more studies are needed to encourage
the use of misoprostol in hysteroscopy.
Only one published study was found about the use of inhalatory
analgesia with nitrous oxide in hysteroscopic polypectomy, which
was performed by our group. To date, no other studies about
analgesia with nitrous oxide in hysteroscopy have been published
in scientiﬁc literature, although it has been widely used for other
painful procedures, such as prostate, liver, or bone marrow bi-
opsy.39 Nitrous oxide is an inhalatory gas that provides short-action
analgesia without respiratory depression. VAS scores for outpatient
hysteroscopic polypectomy in our pilot study were 5.49, 4.22, and
3.55 for the control group, paracervical inﬁltration, and nitrous
oxide, respectively (p < 0.05).39 Although this pilot study has many
limitations, we are actually performing a wide randomized
controlled clinical trial comparing nitrous oxide with paracervical
block and a control group. Conclusions cannot be drawn until the
global trial is ﬁnished and results are analyzed.Conclusion
Individual studies examining the effect of anesthetics and an-
algesics for pain control in outpatient hysteroscopy provide
controversial results. The lack of uniformity in the published papers
makes it difﬁcult to draw conclusions. Although ambitious, this
review's aim is probably too wide, attempting to assess the subject
of analgesia for hysteroscopy, which presents many alternatives
and no clear conclusions. A more focused objective would make
research and drawing conclusions easier. Potential biases of this
review include language restriction to only English papers and
publication bias, as only published papers were included, as well as
operator bias and departmental policy bias. Heterogeneity is also
present, due to the variety of studies included, whichwas necessary
to not incur in a too strict selection that could limit our search.
Observational studies were not included in this analysis, due to
their low quality. However, the aim of this paper is to give a wide
view of the available methods of analgesia for ofﬁce hysteroscopy
according to literature and the factors that inﬂuence it, so that we
can take them into account to reduce pain when performing
hysteroscopy.
Future research should be directed to identifying the best
analgesic method for ofﬁce hysteroscopy, to avoid heterogeneity
and the use of ineffective methods that can even cause morbidity,
and to uniﬁcation of doses and techniques that could generate in-
ternational guidelines for this procedure that has no standards for
pain control.
The main conclusion of this revision is that, at present, inject-
able local anesthetics, particularly paracervical inﬁltration, are the
methods that seem more effective, according to the revised litera-
ture.8,18,25,27,28 Other local anesthetics via topical or intrauterine
route seem to be ineffective.9,25,31 An adequate selection of local
anesthetic is important to control pain during the procedure and
avoid toxicity.9
NSAIDs seem useful to alleviate pain in the postoperative
period.21 No clear evidence has been found to encourage the use of
misoprostol in ofﬁce hysteroscopy.37,38 Inhalatory analgesia with
nitrous oxide offers promising results, but more studies have to be
performed to prove its effectiveness.39
Nonpharmacological methods could also be useful in reducing
hysteroscopy-related pain, such as a ‘no-touch’ approach with
vaginoscopy and minihysteroscopes, reducing waiting time before
hysteroscopy, and the use of music during the procedure to reduce
anxiety.16,17 Risk and protective factors of suffering pain during
outpatient hysteroscopy are important for identifying patients who
are susceptible to receiving anesthesia. Risk factors include
C. del Valle et al. / Gynecology and Minimally Invasive Therapy 5 (2016) 141e147 147menopause, nulliparity, dysmenorrhea, and a longer time of pro-
cedure.3,13,15,16 Experience of the hysteroscopist is a signiﬁcant
protective factor against pain perception during hysteroscopy.13,16
A correct selection of the patient and the analgesic method is the
key to painless outpatient hysteroscopy.
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